Insider Ledger
Harrow, Inc. (HROW) insider buying and SEC filings
Harrow, Inc. · CIK 1360214
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- HARROW HEALTH, INC.; Imprimis Pharmaceuticals, Inc.; TRANSDEL PHARMACEUTICALS INC; Bywater Resources, Inc
Insider activity in the last 12 months
Bought
$469K
Insiders who bought
4
Sold (not marked 10b5-1)
$9.2M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 18, 2026 | Purchase (code P) | Adrienne L Graves (Director) bought 1,000 shares at $31.07 ($31K), reported as a purchase (code P). New position of 1,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 18, 2026 | Purchase (code P) | Lauren P. Silvernail (Director) bought 1,000 shares at $31.00 ($31K), reported as a purchase (code P). New position of 1,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 14, 2026 | Purchase (code P) | Mark L. Baum (CEO and Director) bought 10,000 shares at about $30.20 ($302K), reported as a purchase (code P). Holdings up <1% to 2,996,130 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 15, 2026 |
| May 14, 2026 | Open-market purchase | Andrew R. Boll (CFO) bought 3,500 shares at $29.90 ($105K) in an open-market purchase. Holdings up <1% to 814,679 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 15, 2026 |
| Mar 3–4, 2026 | Sale | Opaleye Management Inc. (10% owner) sold 198,572 shares indirectly (by entity) between Mar 3 and Mar 4 at about $39.51 ($7.8M). Holdings by entity down 5% to 3,622,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Feb 27, 2026 | Sale | Opaleye Management Inc. (10% owner) sold 5,000 shares indirectly at $54.18 ($271K). Indirect holdings down 7% to 65,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Jan 6, 2026 | Sale | Opaleye Management Inc. (10% owner) sold 20,000 shares indirectly at about $53.35 ($1.1M). Indirect holdings down 22% to 70,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 8, 2026 |
9 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$469K in purchases since May 14, 2026 · Purchases traded May 14, 2026 to May 18, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Andrew R. Boll (CFO) | $105K | May 14, 2026 | SEC filing |
| Mark L. Baum (CEO) | $302K | May 14, 2026 | SEC filing |
| Lauren P. Silvernail (Director) | $31K | May 18, 2026 | SEC filing |
| Adrienne L Graves (Director) | $31K | May 18, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HROW in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.